From its earliest days, the founding leadership envisioned this college as a postgraduate and research-oriented centre of excellence — a vision that continues to guide every strategic decision the institution makes today.
The initial phase focused on establishing a strong foundation through the undergraduate B.Pharm programme, followed by the introduction of the D.Pharm programme in the fourth year. Subsequently, sustained efforts were undertaken to bridge the gap between Council regulations and the standards of an ideal institution. Advanced analytical instruments — including High Performance Liquid Chromatography (HPLC) — were installed to upgrade the laboratories to a full-fledged standard.
As part of its infrastructural and regulatory development, the institution plans to obtain all mandatory statutory certifications during 2025, including the Pollution Control Board Certificate, Fire and Safety Certificate, Persons with Disabilities (PwD) Certificate, Alcohol Licence, and Poison Permit. The rear boundary wall was completed in 2025, and significant upgrades were carried out in the museum and computer centre. In parallel, the institution is working towards achieving a minimum 50% pass percentage across all semesters — a prerequisite for applying for postgraduate programmes such as M.Pharm (Pharmacy Practice) and Pharm.D in 2026.
The institution's primary strategic objective is to secure university approval for postgraduate programmes — including M.Pharm (Pharmacy Practice) and Pharm.D — within the next two years. To support this goal and enhance academic governance, the College aims to obtain ISO 21001 certification within the same timeframe, which will also pave the way for participation in the National Institutional Ranking Framework (NIRF).
Simultaneously, the College plans to forge Memoranda of Understanding (MoUs) with pharmaceutical companies, professional organizations, non-governmental organizations, and voluntary organizations engaged in social work. These collaborations will mentor research scholars in writing competitive proposals and securing external funding from research agencies.
Looking ahead, the institution proposes to introduce a language laboratory to bolster English proficiency among students. The computer laboratories will be upgraded with advanced software, equipping students for emerging fields such as business analytics, bioinformatics, and biostatistics. The academic vision also includes training in dissolution studies, pharmacokinetic challenges, and frontier areas of clinical research such as network pharmacology and drug repurposing.
Concurrent efforts are underway to constitute an Institutional Ethics Committee (IEC) and obtain approval from the Central Drugs Standard Control Organization (CDSCO), enabling pharmacy practice–oriented doctoral research and health policy research to progress unhindered. The hospital pharmacy is proposed to be upgraded into a PCI-approved training centre for pharmacists.
The institution aims to achieve NAAC accreditation in 2027, paving the way for its transformation into a centre of excellence in pharmacy education, research, and professional practice.
